Polymer Factory Sweden AB is pleased to announce the successful completion and shipment of a significant order of dendritic nanomaterials to a leading international biopharmaceutical company specializing in RNA therapeutics. The materials have now been delivered and will support the customer's ongoing RNA-based product development.
Mats Wallnér, CEO of Polymer Factory, commented:
"We are proud to have fulfilled this strategic delivery, which demonstrates both our operational reliability and the strong alignment between our advanced materials and the innovation needs of the RNA therapeutics sector. Our relationship with this customer continues to evolve, and we remain optimistic about deepening our collaboration moving forward."
This delivery marks an important milestone in Polymer Factory's continued expansion into high-impact areas of life science. The company's ability to deliver specialized, high-performance dendritic systems positions it as a trusted partner to leading developers in the field of next-generation therapeutics.